Clinical practice of defibrillator implantation after myocardial infarction: impact of implant time: results from the PreSCD II registry.

Standard

Clinical practice of defibrillator implantation after myocardial infarction: impact of implant time: results from the PreSCD II registry. / Völler, Heinz; Kamke, Wolfram; Klein, Helmut U; Block, Michael; Reibis, Rona; Treusch, Sven; Contzen, Klaus; Wegscheider, Karl; Investigators, PreSCD II Registry.

in: EUROPACE, Jahrgang 13, Nr. 4, 4, 2011, S. 499-508.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Völler, H., Kamke, W., Klein, H. U., Block, M., Reibis, R., Treusch, S., Contzen, K., Wegscheider, K., & Investigators, PCD. II. R. (2011). Clinical practice of defibrillator implantation after myocardial infarction: impact of implant time: results from the PreSCD II registry. EUROPACE, 13(4), 499-508. [4]. http://www.ncbi.nlm.nih.gov/pubmed/21123220?dopt=Citation

Vancouver

Bibtex

@article{a3e2c0068da24cb09560338bc6437cbc,
title = "Clinical practice of defibrillator implantation after myocardial infarction: impact of implant time: results from the PreSCD II registry.",
abstract = "Current guidelines recommend implantable cardioverter-defibrillator (ICD) therapy for primary prevention of sudden cardiac death in patients with the reduced left ventricular function (LVEF 30%) not earlier than 40 days after myocardial infarction (MI). The aim of the prospective Prevention of Sudden Cardiac Death II (PreSCD II) registry was to investigate the clinical practice of ICD therapy in post-MI patients and to assess the impact on survival.",
author = "Heinz V{\"o}ller and Wolfram Kamke and Klein, {Helmut U} and Michael Block and Rona Reibis and Sven Treusch and Klaus Contzen and Karl Wegscheider and Investigators, {PreSCD II Registry}",
year = "2011",
language = "Deutsch",
volume = "13",
pages = "499--508",
journal = "EUROPACE",
issn = "1099-5129",
publisher = "Oxford University Press",
number = "4",

}

RIS

TY - JOUR

T1 - Clinical practice of defibrillator implantation after myocardial infarction: impact of implant time: results from the PreSCD II registry.

AU - Völler, Heinz

AU - Kamke, Wolfram

AU - Klein, Helmut U

AU - Block, Michael

AU - Reibis, Rona

AU - Treusch, Sven

AU - Contzen, Klaus

AU - Wegscheider, Karl

AU - Investigators, PreSCD II Registry

PY - 2011

Y1 - 2011

N2 - Current guidelines recommend implantable cardioverter-defibrillator (ICD) therapy for primary prevention of sudden cardiac death in patients with the reduced left ventricular function (LVEF 30%) not earlier than 40 days after myocardial infarction (MI). The aim of the prospective Prevention of Sudden Cardiac Death II (PreSCD II) registry was to investigate the clinical practice of ICD therapy in post-MI patients and to assess the impact on survival.

AB - Current guidelines recommend implantable cardioverter-defibrillator (ICD) therapy for primary prevention of sudden cardiac death in patients with the reduced left ventricular function (LVEF 30%) not earlier than 40 days after myocardial infarction (MI). The aim of the prospective Prevention of Sudden Cardiac Death II (PreSCD II) registry was to investigate the clinical practice of ICD therapy in post-MI patients and to assess the impact on survival.

M3 - SCORING: Zeitschriftenaufsatz

VL - 13

SP - 499

EP - 508

JO - EUROPACE

JF - EUROPACE

SN - 1099-5129

IS - 4

M1 - 4

ER -